UCB Pharma Overview
- Founded
- 1946
- Status
- Acquired/Merged
- Employees
- 8,506
- Latest Deal Type
- M&A
- Financing Rounds
- 2
- Investments
- 1
UCB Pharma General Information
Description
Developer and marketer of drugs. The company specializes in the research, development and market of drugs, pharmaceutical and biotechnological products.
Contact Information
Website
ucb.de
Formerly Known As
Schwarz Pharma AG
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Office
- Alfred-Nobel-Strasse 10
- 40789 Monheim
- Germany
+49 02173 000000
UCB Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore UCB Pharma‘s full profile, request access.
Request a free trialUCB Pharma Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer and marketer of drugs. The company specializes in the research, development and market of drugs, pharmaceutica
Pharmaceuticals
Monheim, Germany
8,506
As of 2011
0.000
0000-00-00
000000&0
00000000
ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore e
000000000000000
Mexico City, Mexico
000.00
0000000 0000
00000000
e eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui offici
000000000000000
Tokyo, Japan
00000
As of 0000
000000000000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialUCB Pharma Competitors (38)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Landsteiner Scientific | Private Equity-Backed | Mexico City, Mexico | 000.00 | 0000000 0000 | ||
| 00000000 000000 | Corporate Backed or Acquired | Tokyo, Japan | 00000 | 000000000000 | ||
| 000000000000000 | Corporation | Brentford, United Kingdom | 000000 | 000000000 | ||
| 00000 000000000000 | Private Equity-Backed | Atlanta, GA | 000 | 000.00 | 0000000000 | |
| 0000000 0000000000 | Corporation | Yilan City, Taiwan | 00 |
UCB Pharma Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Eric Schemann | Geschäftsführung | ||
| Peter Mitterhofer | Geschäftsführung | ||
| Mark Mcdade | Chief Operating Officer |
UCB Pharma Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialUCB Pharma Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 00000000000 | 22-Nov-2011 | 000000000000000000 | Therapeutic Devices |